What’s new at CompuMark for pharmaceutical companies

Developing a PTO-approved mark is a challenge for any organization. But for pharmaceutical companies, the journey doesn’t end there. US Food and Drug Administration (FDA) requirements mean a second set of considerations. At CompuMark™, we are committed to providing you with best-in-class products and services designed to navigate these challenges.

As a result of improvements we are making to SERION, the platform will be unavailable Saturday July 27th, from 12am EST/6am CEST until 6 pm EST/midnight CEST. We apologize for any inconvenience.
close-image